Susan E. Quaggin, MD, FASN, is a graduate of the University of Toronto where she completed her residency and served as chief medical resident for the University’s St. Michael’s Hospital. She completed her nephrology fellowship at the University of Toronto and Yale University, where she also completed research and post-doctoral training. Dr. Quaggin also trained in the developmental biology program at the University of Toronto’s Samuel Lunenfeld Research Institute.
Dr. Quaggin’s research interests include a focus on fundamental genetic pathways required to establish and maintain the integrity of the specialized vascular beds in the kidney and eye. To understand and identify new therapeutic targets, she’s worked to develop numerous genetic mouse models that allow cell and time-specific manipulation of functional genes. Translation of her group’s findings regarding the vasculature reveals pathogenic mechanisms and new therapeutic targets for a number of diseases, including diabetic nephropathy and retinopathy, nephrotic syndrome, and glaucoma.
Currently she is the Charles Horace Mayo professor of medicine at Northwestern University where she serves as the Chief of the Division of Nephrology & Hypertension and the Director of the Feinberg Cardiovascular and Renal Research Inst. Dr. Quaggin was elected to the American Society for Clinical Investigation in 2006 and the Association of American Physicians in 2013 and is a member of the External Scientific Panel of Astra Zeneca and CSO of Mannin Research. She currently serves as a councilor and future President of the American Society of Nephrology and Chair of the PBKD NIH Study Section.